Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
Clinical trial NCT00336557 · COMPLETED
Trial details
- NCT number
- NCT00336557
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-04-01
- Enrollment
- 1230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.